|
|
|
|
J&J Wins $1.67B Remicade Infringement Suit
LOS ANGELES (AP) - A unit of Johnson & Johnson said Monday that a federal jury has ordered Abbott Laboratories to pay $1.67 billion in a patent infringement suit over the companies' rheumatoid arthritis drugs.Abbott's best-selling...
|
|
|
Barron's(7/6) Tech Trader: Marshalling Evi
Two government reports Tuesday offered early hints of the potential industry impact of a $1.1 billion federal program to compare the medical benefit and cost-effectiveness of surgeries, medicines and medical devices.The reports -- by the...
|
|
|
U. Iowa sues drugmaker alleging patent infringement
Source: The Daily Iowan, U.Iowa The University of Iowa is involved in a legal dispute with the makers of Humira, for allegedly intentionally violating two UI patented medical tools. The same company Abbott Labs lost a patent...
|
|
|
UI sues drugmaker alleging patent infringement
The UI is involved in a legal dispute with the makers of Humira, for allegedly intentionally violating two UI patented medical tools.The same company Abbott Labs lost a patent lawsuit Monday, when an eastern Texas federal jury found...
|
|
|
Abbott Labs loses $1.7 billion Humira patent lawsuit to Johnson & Johnson [Chicago Tribune]
30--In one of the largest patent verdicts in U.S.history, a federal jury Monday said Abbott Laboratories should pay nearly $1.7 billion in damages to Johnson & Johnson, which claimed the suburban Chicago drug giant used J&...
|
|
|
Abbott to Pay $1.67B in Patent Suit
At issue was whether or not Abbotts anti-tumor necrosis factor arthritis drug Humira infringed on J&Js blockbuster Remicade, co-owned by New York University and marketed by J&Js bio arm Centocor.Like Remicade, Humira...
|
|
|
Abbott Hit With $1.7B Verdict In IP Suit Over Humira
-- A jury in the U.S.District Court for the Eastern District of Texas has hit Abbott Laboratories with possibly the largest patent verdict in U.S. history, awarding Johnson & Johnson subsidiary Centocor Inc. $1.67 billion and...
|
|
|
J&J Unit Wins $1.7 Billion in Patent Dispute With Abbott
A Texas jury has awarded a Johnson & Johnson (J&J) unit $1.7 billion in a patent infringement dispute involving the blockbuster drug Humira, a treatment for inflammatory diseases such as rheumatoid arthritis.J&Js...
|
|
|
Anatomy of a $1.67 Billion IP Verdict
News of Monday's record-setting $1.67 billion patent verdict against Abbott Labs had patent lawyers slack-jawed across the country.But perhaps even more surprising to some was the lawyer on the losing side: , one of the biggest names in...
|
|
|
Anatomy of a $1.67 Billion IP Verdict
News of Monday's record-setting $1.67 billion patent verdict against Abbott Labs had patent lawyers slack-jawed across the country.But perhaps even more surprising to some was the lawyer on the losing side: , one of the biggest names in...
|
|
|
Anti-TNF Therapies Carry Varying Levels of TB Risk
LITTLE FALLS, N.J., July 2 -- The risk of tuberculosis (TB) is higher for patients receiving anti-tumor necrosis factor (anti-TNF) monoclonal antibody therapy than for those receiving soluble TNF receptor therapy for any indication, French...
|
|
|
Abbott plans to appeal $1.67B patent order
NEW YORK Abbott Laboratories plans to appeal a jury's $1.67 billion patent infringement ruling in a case involving two blockbuster drugs that treat rheumatoid arthritis and other immune disorders.Late Monday, a jury in the Eastern...
|
|
|
Abbott to appeal $2.4b patent
NEW YORK - ABBOTT Laboratories plans to appeal a jury's US$1.67 billion (S$2.41 billion) patent infringement ruling in a case involving two blockbuster drugs that treat rheumatoid arthritis and other immune disorders.Late on Monday, a...
|
|
|
Jury finds Abbott infringed on J&J's patent; Abbott plans to appeal $1.67B ruling
Jury finds Abbott infringed on J&J's patent; Abbott plans to appeal $1.67B ruling NEW YORK - Abbott Laboratories plans to appeal a jury's $1.67 billion patent infringement ruling in a case involving two blockbuster drugs that treat...
|
|
|
Abbott plans to appeal $1.67 billion patent order
NEW YORK (AP) - Abbott Laboratories plans to appeal a jury's $1.67 billion patent infringement ruling in a case involving two blockbuster drugs that treat rheumatoid arthritis and other immune disorders.Late Monday, a jury in the Eastern...
|
|
|
Abbott plans to appeal $1.67 billion patent order
NEW YORK (AP) - Abbott Laboratories plans to appeal a jury's $1.67 billion patent infringement ruling in a case involving two blockbuster drugs that treat rheumatoid arthritis and other immune disorders.Late Monday, a jury in the Eastern...
|
|
|
Abbott vows to appeal loss to Johnson & Johnson over patent case
NEW YORK - Abbott Laboratories plans to appeal a jury's $1.67 billion patent infringement ruling in a case involving two blockbuster drugs that treat rheumatoid arthritis and other immune disorders.Late Monday, a jury in the Eastern...
|
|
|
Abbott plans to appeal $1.67 billion patent order
NEW YORK (AP) - Abbott Laboratories plans to appeal a jury's $1.67 billion patent infringement ruling in a case involving two blockbuster drugs that treat rheumatoid arthritis and other immune disorders.Late Monday, a jury in the Eastern...
|
|
|
Jury finds Abbott infringed on J&J's patent; Abbott plans to appeal $1.67B ruling
Abbott Laboratories plans to appeal a jury's $1.67 billion patent infringement ruling in a case involving two blockbuster drugs that treat rheumatoid arthritis and other immune disorders.Late Monday, a jury in the Eastern District of...
|
|
|
Abbott plans to appeal $1.67 billion patent order
NEW YORK (AP) - Abbott Laboratories plans to appeal a jury's $1.67 billion patent infringement ruling in a case involving two blockbuster drugs that treat rheumatoid arthritis and other immune disorders.Late Monday, a jury in the Eastern...
|
|
|
Abbott plans to appeal $1.67B patent order
NEW YORK -- Abbott Laboratories plans to appeal a jury's $1.67 billion patent infringement ruling in a case involving two blockbuster drugs that treat rheumatoid arthritis and other immune disorders.Late Monday, a jury in the Eastern...
|
|
|
Abbott plans to appeal $1.67B patent order
Abbott Laboratories plans to appeal a jury's $1.67 billion patent infringement ruling in a case involving two blockbuster drugs that treat rheumatoid arthritis and other immune disorders.Late Monday, a jury in the Eastern District of...
|
|
|
Jury returns $1.67 billion drug verdict against Abbott
NEW YORK (Reuters) - A U.S.federal jury returned a $1.67 billion verdict against Abbott Laboratories in a patent suit brought by Johnson & Johnson related to arthritis treatments, the drug companies said on Monday. An Abbott...
|
|
|
Jury returns $1.67 billion drug verdict against Abbott
NEW YORK (Reuters) - A U.S.federal jury returned a $1.67 billion verdict against Abbott Laboratories in a patent suit brought by Johnson & Johnson related to arthritis treatments, the drug companies said on Monday. An Abbott...
|
|
|
Jury finds Abbott infringed on J&J's patent; Abbott plans to appeal $1.67B ruling
Jury finds Abbott infringed on J&J's patent; Abbott plans to appeal $1.67B ruling Marley Seaman, THE ASSOCIATED PRESS The Canadian Press, 2009 NEW YORK - Abbott Laboratories plans to appeal a jury's $1.67 billion patent infringement...
|
